Epista Life Science A/S: Financial statements 2014
CVR: 32141064
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Epista Life Science A/S (CVR 32141064) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 16,152,951 and a net result of DKK 2,378,521 compared with DKK 1,522,575 the year before. That is an increase of 48.8% compared with the year before. Equity in the 2014 report amounted to DKK 1,779,133. The solvency ratio was 23.3%.
- Gross Profit
- DKK 16,152,951
- Profit/Loss
- DKK 2,378,521
- Equity
- DKK 1,779,133
- Total Assets
- DKK 7,620,414
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 16.2M | 2.4M | 1.8M | - |
| 2013 | - | 10.9M | 1.5M | 1.2M | - |
| 2012 | - | 7.8M | 471K | 678K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
Epista Life Science A/S has published its annual report for 2013. Gross profit came to DKK 10,851,968, and the net result was DKK 1,522,575.
About Epista Life Science A/S
Epista Life Science A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2009. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named EPISTA IT A/S and EPISTA IT ApS. The management consists of Per Erik Mikael Johansson. The board consists of Simon Carl Vilhelm Larsson (chair), Katarína Larsen and Klavs Esbjerg. The company is owned by Enhance BidCo ApS. The company has 86 employees (2026). In 2025, the company reported a gross profit of DKK 104,009,512 and a net result of DKK -40,340,814 compared with DKK -12,458,230 the year before. Equity in the 2025 report amounted to DKK 42,811,282.
